Kumada H - Search Results

1

A single nucleotide polymorphism in activated Cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients.

Fujimoto Y, Ochi H, Maekawa T, Abe H, Hayes CN, Kumada H, Nakamura Y, Chayama K. Fujimoto Y, et al. Among authors: kumada h. J Hepatol. 2011 Apr;54(4):629-39. doi: 10.1016/j.jhep.2010.07.021. Epub 2010 Nov 18. J Hepatol. 2011. PMID: 21129804

2

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients.

Arase Y, Tsubota A, Saitoh S, Suzuki Y, Kobayashi M, Suzuki F, Someya T, Akuta N, Ikeda K, Kobayashi M, Kumada H. Arase Y, et al. Among authors: kumada h. Hepatol Res. 2002 Jun;23(2):98-104. doi: 10.1016/s1386-6346(01)00169-3. Hepatol Res. 2002. PMID: 12048063

3

Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy.

Suzuki F, Suzuki Y, Tsubota A, Akuta N, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Suzuki F, et al. Among authors: kumada h. J Hepatol. 2002 Dec;37(6):824-30. doi: 10.1016/s0168-8278(02)00281-7. J Hepatol. 2002. PMID: 12445424

4

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.

Akuta N, Suzuki F, Tsubota A, Suzuki Y, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: kumada h. J Hepatol. 2002 Dec;37(6):831-6. doi: 10.1016/s0168-8278(02)00301-x. J Hepatol. 2002. PMID: 12445425

5

Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.

Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Akuta N, Someya T, Kumada H. Arase Y, et al. Among authors: kumada h. J Gastroenterol. 2003;38(2):158-63. doi: 10.1007/s005350300026. J Gastroenterol. 2003. PMID: 12640530 Clinical Trial.

6

Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.

Tanaka J, Kumada H, Ikeda K, Chayama K, Mizui M, Hino K, Katayama K, Kumagai J, Komiya Y, Miyakawa Y, Yoshizawa H. Tanaka J, et al. Among authors: kumada h. J Med Virol. 2003 Jul;70(3):378-86. doi: 10.1002/jmv.10406. J Med Virol. 2003. PMID: 12767000

7

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C.

Takaki S, Tsubota A, Hosaka T, Akuta N, Someya T, Kobayashi M, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H. Takaki S, et al. Among authors: kumada h. J Gastroenterol. 2004 Jul;39(7):668-73. doi: 10.1007/s00535-003-1363-9. J Gastroenterol. 2004. PMID: 15293138

8

Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy.

Iino S, Tomita E, Kumada H, Suzuki H, Toyota J, Kiyosawa K, Tanikawa K, Sata M, Hayashi N, Kakumu S, Matsushima T, Ohno T. Iino S, et al. Among authors: kumada h. Hepatol Res. 2004 Oct;30(2):63-70. doi: 10.1016/j.hepres.2004.07.002. Hepatol Res. 2004. PMID: 15519269

9

Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels.

Iino S, Tomita E, Kumada H, Suzuki H, Toyota J, Kiyosawa K, Tanikawa K, Sata M, Hayashi N, Kakumu S, Matsushima T, Mizokami M. Iino S, et al. Among authors: kumada h. Hepatol Res. 2005 Feb;31(2):88-94. doi: 10.1016/j.hepres.2004.12.004. Hepatol Res. 2005. PMID: 15777649

10

Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C.

Arase Y, Ikeda K, Tsubota A, Suzuki F, Suzuki Y, Saitoh S, Kobayashi M, Akuta N, Someya T, Hosaka T, Sezaki H, Kobayashi M, Kumada H. Arase Y, et al. Among authors: kumada h. Intervirology. 2005;48(2-3):138-44. doi: 10.1159/000081741. Intervirology. 2005. PMID: 15812187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters